317 related articles for article (PubMed ID: 28872867)
1. Multidrug, Anti-HIV Amorphous Solid Dispersions: Nature and Mechanisms of Impacts of Drugs on Each Other's Solution Concentrations.
Arca HÇ; Mosquera-Giraldo LI; Dahal D; Taylor LS; Edgar KJ
Mol Pharm; 2017 Nov; 14(11):3617-3627. PubMed ID: 28872867
[TBL] [Abstract][Full Text] [Related]
2. Both solubility and chemical stability of curcumin are enhanced by solid dispersion in cellulose derivative matrices.
Li B; Konecke S; Wegiel LA; Taylor LS; Edgar KJ
Carbohydr Polym; 2013 Oct; 98(1):1108-16. PubMed ID: 23987452
[TBL] [Abstract][Full Text] [Related]
3. Novel cellulose-based amorphous solid dispersions enhance quercetin solution concentrations in vitro.
Gilley AD; Arca HC; Nichols BLB; Mosquera-Giraldo LI; Taylor LS; Edgar KJ; Neilson AP
Carbohydr Polym; 2017 Feb; 157():86-93. PubMed ID: 27988001
[TBL] [Abstract][Full Text] [Related]
4. Stability and solubility enhancement of ellagic acid in cellulose ester solid dispersions.
Li B; Harich K; Wegiel L; Taylor LS; Edgar KJ
Carbohydr Polym; 2013 Feb; 92(2):1443-50. PubMed ID: 23399175
[TBL] [Abstract][Full Text] [Related]
5. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
Sarode AL; Malekar SA; Cote C; Worthen DR
Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
[TBL] [Abstract][Full Text] [Related]
6. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
Indulkar AS; Lou X; Zhang GGZ; Taylor LS
Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
[TBL] [Abstract][Full Text] [Related]
7. Solid dispersion of quercetin in cellulose derivative matrices influences both solubility and stability.
Li B; Konecke S; Harich K; Wegiel L; Taylor LS; Edgar KJ
Carbohydr Polym; 2013 Feb; 92(2):2033-40. PubMed ID: 23399255
[TBL] [Abstract][Full Text] [Related]
8. Pairwise polymer blends for oral drug delivery.
Marks JA; Wegiel LA; Taylor LS; Edgar KJ
J Pharm Sci; 2014 Sep; 103(9):2871-2883. PubMed ID: 24823790
[TBL] [Abstract][Full Text] [Related]
9. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
Purohit HS; Taylor LS
Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
[TBL] [Abstract][Full Text] [Related]
10. Interplay of degradation, dissolution and stabilization of clarithromycin and its amorphous solid dispersions.
Pereira JM; Mejia-Ariza R; Ilevbare GA; McGettigan HE; Sriranganathan N; Taylor LS; Davis RM; Edgar KJ
Mol Pharm; 2013 Dec; 10(12):4640-53. PubMed ID: 24116899
[TBL] [Abstract][Full Text] [Related]
11. Compromised in vitro dissolution and membrane transport of multidrug amorphous formulations.
Alhalaweh A; Bergström CAS; Taylor LS
J Control Release; 2016 May; 229():172-182. PubMed ID: 27006280
[TBL] [Abstract][Full Text] [Related]
12. Rifampin Stability and Solution Concentration Enhancement Through Amorphous Solid Dispersion in Cellulose ω-Carboxyalkanoate Matrices.
Arca HÇ; Mosquera-Giraldo LI; Pereira JM; Sriranganathan N; Taylor LS; Edgar KJ
J Pharm Sci; 2018 Jan; 107(1):127-138. PubMed ID: 28601524
[TBL] [Abstract][Full Text] [Related]
13. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
Xie T; Taylor LS
Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
[TBL] [Abstract][Full Text] [Related]
14. Cellulose-based amorphous solid dispersions enhance rifapentine delivery characteristics in vitro.
Winslow CJ; Nichols BLB; Novo DC; Mosquera-Giraldo LI; Taylor LS; Edgar KJ; Neilson AP
Carbohydr Polym; 2018 Feb; 182():149-158. PubMed ID: 29279109
[TBL] [Abstract][Full Text] [Related]
15. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
Jackson MJ; Kestur US; Hussain MA; Taylor LS
Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-property evaluation of cellulose ω-carboxyesters for amorphous solid dispersions.
Liu H; Ilevbare GA; Cherniawski BP; Ritchie ET; Taylor LS; Edgar KJ
Carbohydr Polym; 2014 Jan; 100():116-25. PubMed ID: 24188845
[TBL] [Abstract][Full Text] [Related]
17. Hybrid nanocrystal-amorphous solid dispersions (HyNASDs) as alternative to ASDs for enhanced release of BCS Class II drugs.
Rahman M; Arevalo F; Coelho A; Bilgili E
Eur J Pharm Biopharm; 2019 Dec; 145():12-26. PubMed ID: 31622652
[TBL] [Abstract][Full Text] [Related]
18. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
Baghel S; Cathcart H; O'Reilly NJ
Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
[TBL] [Abstract][Full Text] [Related]
19. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
Xie T; Taylor LS
Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
[TBL] [Abstract][Full Text] [Related]
20. Understanding the generation and maintenance of supersaturation during the dissolution of amorphous solid dispersions using modulated DSC and
Baghel S; Cathcart H; O'Reilly NJ
Int J Pharm; 2018 Jan; 536(1):414-425. PubMed ID: 29183857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
